{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:35:06Z","timestamp":1791329706965,"version":"4.3.1"},"reference-count":39,"publisher":"American Society for Microbiology","issue":"8","license":[{"start":{"date-parts":[[2005,4,15]],"date-time":"2005-04-15T00:00:00Z","timestamp":1113523200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Virol"],"published-print":{"date-parts":[[2005,4,15]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Constitutive activation of signal transducer and activator of transcription 1 (STAT1) is a distinctive feature of Epstein-Barr virus (EBV)-immortalized B cells (lymphoblastoid cell lines [LCLs]). The expression of STAT1 in these cells is modulated by the latent membrane protein 1 (LMP1), but the mechanism of STAT1 activation has remained unclear. We demonstrate that the tyrosine phosphorylation of STAT1 in LCLs results from an indirect pathway encompassing an NF-\u03baB-dependent secretion of interferons (IFNs). The cell culture supernatant of LCLs induced tyrosine phosphorylation of STAT1 in cells with no constitutively activated STAT1. Moreover, removal of supernatant from LCLs was sufficient to decrease the phosphorylation of STAT1. Inhibition of NF-\u03baB activity by different pharmacological inhibitors (i.e., parthenolide, MG132 and BAY 11-7082) and by overexpressed mutated I\u03baB\u03b1 prevented the activation of STAT1. To identify the factors involved, we performed macroarray cDNA profiling with or without inhibition of NF-\u03baB. The expression of several cytokines was NF-\u03baB dependent among those alpha and gamma IFNs (IFN-\u03b1 and IFN-\u03b3), known activators of STAT1. By real-time PCR and enzyme-linked immunosorbent assay we show that IFN-\u03b1 and IFN-\u03b3 are expressed and released by LCLs in an NF-\u03baB-dependent manner. Finally, the blocking of the IFN-\u03b1 and IFN-\u03b3 by neutralizing antibodies led to the complete inhibition of tyrosine phosphorylation of STAT1. Taken together, our results clearly show that LMP1-induced tyrosine phosphorylation of STAT1 is almost exclusively due to the NF-\u03baB-dependent secretion of IFNs. Whether this response, which is usually considered to be antiviral, is in fact required for the persistence of the virus remains to be elucidated.<\/jats:p>","DOI":"10.1128\/jvi.79.8.4936-4943.2005","type":"journal-article","created":{"date-parts":[[2005,3,28]],"date-time":"2005-03-28T18:47:45Z","timestamp":1112035665000},"page":"4936-4943","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":57,"title":["Latent Membrane Protein 1 Regulates STAT1 through NF-\u03baB-Dependent Interferon Secretion in Epstein-Barr Virus-Immortalized B Cells"],"prefix":"10.1128","volume":"79","author":[{"given":"Imen","family":"Najjar","sequence":"first","affiliation":[{"name":"Universite\u0301 Paris 13, UPRES EA 3406, Service de Biochimie AP-HP Ho\u0302pital Avicenne, Bobigny"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"Baran-Marszak","sequence":"additional","affiliation":[{"name":"INSERM E109, Universite\u0301 Paris 11, Service d'He\u0301matologie, Ho\u0302pital Kremlin-Bice\u0302tre, Le Kremlin-Bice\u0302tre"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Le Clorennec","sequence":"additional","affiliation":[{"name":"CNRS UMR 6101 and Laboratoire d'He\u0301matologie, Universite\u0301 de Limoges, Faculte\u0301 de Me\u0301decine, CHU Dupuytren, Limoges, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle","family":"Laguillier","sequence":"additional","affiliation":[{"name":"INSERM E109, Universite\u0301 Paris 11, Service d'He\u0301matologie, Ho\u0302pital Kremlin-Bice\u0302tre, Le Kremlin-Bice\u0302tre"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Schischmanoff","sequence":"additional","affiliation":[{"name":"Universite\u0301 Paris 13, UPRES EA 3406, Service de Biochimie AP-HP Ho\u0302pital Avicenne, Bobigny"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibtissam","family":"Youlyouz-Marfak","sequence":"additional","affiliation":[{"name":"CNRS UMR 6101 and Laboratoire d'He\u0301matologie, Universite\u0301 de Limoges, Faculte\u0301 de Me\u0301decine, CHU Dupuytren, Limoges, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Schlee","sequence":"additional","affiliation":[{"name":"GSF-Institute of Clinical Molecular Biology and Tumor Genetics, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg W.","family":"Bornkamm","sequence":"additional","affiliation":[{"name":"GSF-Institute of Clinical Molecular Biology and Tumor Genetics, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Raphae\u0308l","sequence":"additional","affiliation":[{"name":"INSERM E109, Universite\u0301 Paris 11, Service d'He\u0301matologie, Ho\u0302pital Kremlin-Bice\u0302tre, Le Kremlin-Bice\u0302tre"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Feuillard","sequence":"additional","affiliation":[{"name":"CNRS UMR 6101 and Laboratoire d'He\u0301matologie, Universite\u0301 de Limoges, Faculte\u0301 de Me\u0301decine, CHU Dupuytren, Limoges, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remi","family":"Fagard","sequence":"additional","affiliation":[{"name":"Universite\u0301 Paris 13, UPRES EA 3406, Service de Biochimie AP-HP Ho\u0302pital Avicenne, Bobigny"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-3-1"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.LAB.0000035025.51772.2B"},{"key":"e_1_3_2_4_2","first-page":"2475","volume":"104","year":"2004","unstructured":"Baran-Marszak, F., J. Feuillard, I. Najjar, C. Le Clorennec, J. M. Bechet, I. Dusanter-Fourt, G. W. Bornkamm, M. Rapha\u00ebl, and R. Fagard. 2004. Differential roles of STAT1\u03b1 and STAT1\u03b2 in fludarabine-induced cell cycle arrest and apoptosis in human B cells. Blood104:2475-2483.","journal-title":"Blood"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M005461200"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/0166-3542(83)90026-8"},{"key":"e_1_3_2_7_2","first-page":"44","volume":"159","year":"2002","unstructured":"Cahir-McFarland, E., and E. Kieff. 2002. NF-\u03baB inhibition in EBV-transformed lymphoblastoid cell lines. Cancer Res.159:44-48.","journal-title":"Cancer Res."},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.78.8.4108-4119.2004"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.76.20.10427-10436.2002"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.75.6.2929-2937.2001"},{"key":"e_1_3_2_11_2","first-page":"4473","volume":"29","year":"2002","unstructured":"Fagard, R., H. Mouas, I. Dusanter-Fourt, C. Devillers, P. Bissieres, A. Martin, G. M. Lenoir, H. VanTan, J. Feuillard, and M. Rapha\u00ebl. 2002. Resistance to fludarabine-induced apoptosis in Epstein-Barr virus-infected B cells. Oncogene29:4473-4480.","journal-title":"Oncogene"},{"key":"e_1_3_2_12_2","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.4049\/jimmunol.158.6.2585","volume":"158","year":"1997","unstructured":"Feuillard, J., C. Dargemont, V. Ferreira, N. Tarantino, P. Debr\u00e9, M. Rapha\u00ebl, and M. Korner. 1997. Nuclear Rel-A and c-Rel protein complexes are differentially distributed within human thymocytes. J. Immunol.158:2585-2591.","journal-title":"J. Immunol."},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/1043-4666(91)90025-9"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V95.6.2068.2068"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1201359"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403135"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-04-1128"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/18.11.3064"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/16.20.6131"},{"key":"e_1_3_2_20_2","doi-asserted-by":"crossref","first-page":"5617","DOI":"10.4049\/jimmunol.163.10.5617","volume":"163","year":"1999","unstructured":"Hehner, S. P., T. G. Hofmann, W. Droge, and M. L. Schmitz. 1999. The antiinflammatory sesquiterpene lactone parthenolide inhibits NF-\u03baB by targeting the I\u03baB kinase complex. J. Immunol.163:5617-5623.","journal-title":"J. Immunol."},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.76.1.455-459.2002"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.23.12592"},{"key":"e_1_3_2_23_2","first-page":"9150","volume":"19","year":"1993","unstructured":"Kaye, K. M., K. M. Izumi, and E. Kieff. 1993. Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. Proc. Natl. Acad. Sci. USA19:9150-9154.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.116.5.1071"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M205165200"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1207332"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.2001.4913"},{"key":"e_1_3_2_28_2","first-page":"6853","volume":"49","year":"1999","unstructured":"Pahl, H. L. 1999. Activators and target genes of Rel\/NF-B transcription factors. Oncogene49:6853-6866.","journal-title":"Oncogene"},{"key":"e_1_3_2_29_2","first-page":"1775","volume":"7","year":"1992","unstructured":"Peng, M., and E. Lundgren. 1992. Transient expression of the Epstein-Barr virus LMP1 gene in human primary B cells induces cellular activation and DNA synthesis. Oncogene7:1775-1782.","journal-title":"Oncogene"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.77.7.4439-4443.2003"},{"key":"e_1_3_2_31_2","unstructured":"Rickinson A. and E. Kieff. 2001. Epstein-Barr virus p. 2573-2627. In D. Knipe P. Howley D. Griffin R. Lamb M. Martin B. Roizman and S. Straus (ed.) Virology 4th ed. Lippincott\/The Williams & Wilkins Co. Philadelphia Pa."},{"key":"e_1_3_2_32_2","unstructured":"Rickinson A. B. and E. Kieff. 1996. Epstein-Barr virus p. 2397-2446. In D. M. Knipe B. N. Fields and P. M. Howley (ed.) Virology 3rd ed. vol. 2. Lippincott-Raven Philadelphia Pa."},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.48.30412"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1038\/35073080"},{"key":"e_1_3_2_35_2","first-page":"4610","volume":"20","year":"1996","unstructured":"Wang, S., M. Rowe, and E. Lundgren. 1996. Expression of the Epstein-Barr virus transforming protein LMP1 causes a rapid and transient stimulation of the Bcl-2 homologue Mcl-1 levels in B-cell lines. Cancer Res.20:4610-4613.","journal-title":"Cancer Res."},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V88.3.809.809"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.62.1.218-225.1988"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1203515"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2004.03.007"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1089\/107999002753452700"}],"container-title":["Journal of Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JVI.79.8.4936-4943.2005","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JVI.79.8.4936-4943.2005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T11:17:34Z","timestamp":1706095054000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JVI.79.8.4936-4943.2005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4,15]]},"references-count":39,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2005,4,15]]}},"alternative-id":["10.1128\/JVI.79.8.4936-4943.2005"],"URL":"https:\/\/doi.org\/10.1128\/jvi.79.8.4936-4943.2005","relation":{},"ISSN":["0022-538X","1098-5514"],"issn-type":[{"value":"0022-538X","type":"print"},{"value":"1098-5514","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,4,15]]},"assertion":[{"value":"2004-07-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2004-10-26","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2005-04-15","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}